Indoco Remedies Ltd. — Board/Management Information 2021

Nov 2, 2021

==> picture [187 x 66] intentionally omitted <==

November 02, 2021

To To The Listing Department The Listing Department National Stock Exchange of India Limited Bombay Stock Exchange Limited Exchange Plaza, Floor 25, P. J. Towers, Bandra – Kurla Complex Dalal Street, Bandra (East) Mumbai – 400 001 Mumbai – 400 051 Stock Code : INDOCO-EQ Stock Code : 532612

Dear Sir

Sub: Intimation of re-appointment of Managing Director and Jt. Managing Director

In compliance with Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, this is to inform you that based on the recommendation of Nomination and Remuneration Committee and subject to approval of the shareholders and any required regulatory approvals and applicable conditions thereof the Board of Directors at its meeting held on 2[nd] November, 2021 has considered and approved the following:

• The reappointment of Ms. Aditi Panandikar (DIN 00179113), Managing Director of the Company for a further period of five (5) years w.e.f. 15[th] February 2022 to 14[th] February 2027 (both days inclusive).

• The reappointment of Mr. Sundeep V Bambolkar (DIN 00176613), Jt. Managing Director of the Company for a further period of five (5) years w.e.f. 15[th] February 2022 to 14[th] February 2027 (both days inclusive).

The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9[th] September 2015 along with the brief profile is given in Annexure A to this letter.

Thanking you,

Yours faithfully,

For Indoco Remedies Limited

==> picture [61 x 59] intentionally omitted <==

Jayshankar Menon Company Secretary & AVP Legal

==> picture [557 x 72] intentionally omitted <==

==> picture [187 x 66] intentionally omitted <==

ANNEXURE A

==> picture [413 x 528] intentionally omitted <==

----- Start of picture text ----- Name of the Director Ms. Aditi Panandikar Mr. Sundeep V BambolkarDIN 00179113 00176613Reason for change viz Re-appointment of Ms. Aditi Re-appointment of Mr. SundeepReappointment Panandikar (DIN 00179113) V Bambolkar (DIN 00176613)designated as Managing Director designated as Jt. Managingpursuant to the end of her current Director pursuant to the end of histerm for a further period of Five current term for a further period of(5) years wef 15 [th] February 2022 Five (5) years wef 15 [th] Februaryto 14 [th] February, 2027 (both days 2022 to 14 [th] February, 2027 (bothinclusive) days inclusive)Date of Reappointment Reappointment for a further Reappointment for a furtherand Term of period of Five (5) years wef 15 [th] period of Five (5) years wef 15 [th]Reappointment February 2022 to 14 [th] February, February 2022 to 14 [th] February,2027 (both days inclusive) 2027 (both days inclusive)She would be liable to retire by He would be liable to retire byrotation rotationBrief Profile Ms. Aditi Panandikar is a third A Pharma professional with overgeneration entrepreneur with 35 years’ experience in thesharp business acumen and industry, across various functionstechno-commercial skills. She is a such as Finance, Operations,graduate in Pharmacy, holds a Purchase, Projects andMaster’s Degree in International BusinessPharmaceutical Administrationfrom the Ohio State University, Mr. Sundeep V. Bambolkar hasUSA. Patent Law and practices is been with Indoco since 1982. Heanother area in which she has was appointed as Jt. Managingpursued an in-depth study. Director of Indoco in February2012.Ms. Aditi Panandikar wasappointed as Managing Director Prior to this, he was a Boardof Indoco in February 2012. Member with responsibilities ofFinance, Operations andPrior to her elevation as International Business. As Jt.Managing Director, Ms. Aditi has Managing Director, he is overallhandled at Indoco, various responsible for all Manufacturingfunctions like, Domestic as well as Supply ChainMarketing - Formulations, API Operations for FormulationBusiness, HR, Technical (R&D & Business, Finance and alliedQA) and Business Development functions.(International)Disclosure of Ms. Aditi Panandikar is related to NARelationships between Mr. Suresh G Kare- Chairman ofDirectors the Company----- End of picture text -----

==> picture [557 x 72] intentionally omitted <==

==> picture [187 x 66] intentionally omitted <==

Information as required Ms. Aditi Panandikar is not pursuant to BSE circular debarred from holding the office Ref. No. LIST / COMP / of Director by virtue of any SEBI 14 / 2018-19 and The order or any other such authorities Natiomal Stock Exchange of India and NSE circular Ref. No. NSE / CML / 2018 / 24 dated 20[th] June, 2018

Mr. Sundeep V Bambolkar is not debarred from holding the office of Director by virtue of any SEBI order or any other such authorities.

For Indoco Remedies Limited

==> picture [60 x 58] intentionally omitted <==

Jayshankar Menon Company Secretary & AVP Legal

==> picture [557 x 72] intentionally omitted <==